- Report
- February 2026
- 117 Pages
Europe
From €5545EUR$5,995USD£4,634GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5545EUR$5,995USD£4,634GBP
- Report
- January 2026
- 79 Pages
Middle East, Africa
From €3191EUR$3,450USD£2,667GBP
- Report
- January 2026
- 92 Pages
Asia Pacific
From €3653EUR$3,950USD£3,053GBP
- Report
- January 2026
- 96 Pages
Europe
From €3653EUR$3,950USD£3,053GBP
- Report
- January 2026
- 86 Pages
North America
From €3191EUR$3,450USD£2,667GBP
- Report
- November 2023
- 127 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3330EUR$3,600USD£2,783GBP
- Report
- January 2023
- 127 Pages
Global
From €2081EUR$2,250USD£1,739GBP
- Report
- April 2021
Global
From €832EUR$900USD£696GBP
- Report
- August 2025
- 154 Pages
Global
From €2451EUR$2,650USD£2,048GBP
- Report
- June 2025
- 379 Pages
Global
From €4578EUR$4,950USD£3,826GBP
- Report
- June 2025
- 151 Pages
Global
From €3237EUR$3,500USD£2,706GBP
- Report
- March 2022
- 260 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- August 2026
- 200 Pages
Saudi Arabia
From €2303EUR$2,490USD£1,925GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2303EUR$2,490USD£1,925GBP
- Report
- February 2026
- 200 Pages
Australia
From €2765EUR$2,990USD£2,311GBP
- Report
- August 2025
- 200 Pages
United States
From €2303EUR$2,490USD£1,925GBP
- Report
- August 2025
- 200 Pages
United States
From €2303EUR$2,490USD£1,925GBP
- Report
- August 2025
- 200 Pages
Global
From €2303EUR$2,490USD£1,925GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more